Join us at the Cell & Gene Therapy Manufacturing & Commercialization US 2023, the premier event dedicated to revolutionizing the field of cell and gene therapy manufacturing, commercialization, and supply chain strategies. As the leading conference in this rapidly advancing field, we bring together world-renowned leaders, researchers, and industry experts to share groundbreaking bioprocessing science and technologies that will shape the future of manufacturing scalability, cost, and quality.
With over 2700 global attendees, 200+ exhibitors, 150+ scientific posters, and 5 conference tracks, this event offers an unparalleled opportunity to network with key stakeholders and gain insights into the latest advancements in cell and gene therapy production. Our esteemed speakers will present cutting-edge case studies that highlight strategies to enhance efficiencies and accelerate the delivery of life-changing therapies to patients, particularly those with rare diseases.
Throughout the event, attendees will have the chance to engage in thought-provoking discussions, attend interactive workshops, and participate in dynamic sessions that cover a wide range of topics, including process optimization, manufacturing automation, regulatory considerations, supply chain management, and patient access. By exploring these key areas, we aim to facilitate collaboration, foster innovation, and drive transformative changes in the field of cell and gene therapy manufacturing.
Whether you are a scientist, researcher, clinician, industry professional, or investor, this event is a must-attend for anyone looking to stay at the forefront of the rapidly evolving landscape of cell and gene therapies. Join us at the Cell & Gene Therapy Manufacturing & Commercialization US 2023 and be part of the global movement to improve manufacturing processes, expand patient access, and transform the lives of individuals living with challenging medical conditions.